CDK
Cyclin dependent kinase
CDKs (Cyclin-dependent kinases) are serine-threonine kinases first discovered for their role in regulating the cell cycle. They are also involved in regulating transcription, mRNA processing, and the differentiation of nerve cells. CDKs are relatively small proteins, with molecular weights ranging from 34 to 40 kDa, and contain little more than the kinase domain. In fact, yeast cells can proliferate normally when their CDK gene has been replaced with the homologous human gene. By definition, a CDK binds a regulatory protein called a cyclin. Without cyclin, CDK has little kinase activity; only the cyclin-CDK complex is an active kinase.
There are around 20 Cyclin-dependent kinases (CDK1-20) known till date. CDK1, 4 and 5 are involved in cell cycle, and CDK 7, 8, 9 and 11 are associated with transcription.
CDK levels remain relatively constant throughout the cell cycle and most regulation is post-translational. Most knowledge of CDK structure and function is based on CDKs of S. pombe (Cdc2), S. cerevisia (CDC28), and vertebrates (CDC2 and CDK2). The four major mechanisms of CDK regulation are cyclin binding, CAK phosphorylation, regulatory inhibitory phosphorylation, and binding of CDK inhibitory subunits (CKIs).
CDK Isoform Specific Products
-
CDK
(487)
View all products
-
CDK1
(196)
View all products
-
CDK2
(315)
View all products
-
CDK3
(28)
View all products
-
CDK4
(233)
View all products
-
CDK5
(98)
View all products
-
CDK6
(178)
View all products
-
CDK7
(119)
View all products
-
CDK8
(57)
View all products
-
CDK9
(205)
View all products
-
CDK11
(9)
View all products
-
CDK12
(53)
View all products
-
CDK13
(27)
View all products
-
CDK14
(6)
View all products
-
CDK16
(8)
View all products
-
CDK19
(25)
View all products
-
CDC
(21)
View all products
-
CLK
(31)
View all products
-
Pho85
(1)
View all products
-
CDK10
(1)
View all products
-
CDK15
(1)
View all products
-
CDK17
(2)
View all products
-
CDK18
(1)
View all products
-
CDK20
(1)
View all products
-
PITSLRE
(1)
View all products
All Product Categories
-
CDK Inhibitors
(1077)
View all products
-
CDK Agonists
(3)
View all products
-
CDK Antagonists
(2)
View all products
-
CDK Activators
(18)
View all products
-
CDK Modulators
(15)
View all products
-
CDK Degraders
(95)
View all products
-
CDK Controls
(4)
View all products
-
CDK Substrate
(1)
View all products
-
CDK Ligands
(16)
View all products
-
Cyclin-Dependent Kinases (CDKs) Proteins
(80)
View all products
-
Cyclin Dependent Kinase 1 (CDK1) Proteins
(9)
View all products
-
Cyclin-Dependent Kinase 2 (CDK2) Proteins
(12)
View all products
-
Cyclin-Dependent Kinase 3 (CDK3) Proteins
(6)
View all products
-
Cyclin-Dependent Kinase 4 (CDK4) Proteins
(4)
View all products
-
Cyclin-Dependent Kinase 5 (CDK5) Proteins
(5)
View all products
-
Cyclin-Dependent Kinase 6 (CDK6) Proteins
(6)
View all products
-
Cyclin-Dependent Kinase 7 (CDK7) Proteins
(4)
View all products
-
CDK Produits associés (1353)
Produits associés (1353)
-
Protéines Recombinantes (82)
-
Anticorps (42)
-
CDK Isoform Comparison
- ARN25499
-
loading...Please select quantityObtenir un devis
August 31
-
Please select quantity
August 31
Obtenir un devis
loading... -
- Antitumor agent-104
-
loading...Please select quantityObtenir un devis
August 31
-
Please select quantity
August 31
Obtenir un devis
loading... -
-
PARP-1/2-IN-2
0 ImagesCat. No.: HY-149398CAS No.: 3052304-23-8 -
loading...Please select quantityObtenir un devis
August 31
-
Please select quantity
August 31
Obtenir un devis
loading... -
-
EGFR/HER2/CDK9-IN-2
0 ImagesCat. No.: HY-147797CAS No.: 1180924-34-8 -
loading...Please select quantityObtenir un devis
August 31
-
Please select quantity
August 31
Obtenir un devis
loading... -
-
Cdk16 Rat Pre-designed siRNA Set A
0 ImagesCat. No.: HY-RS02368 -
loading...Please select quantityObtenir un devis
August 31
-
Please select quantity
August 31
Obtenir un devis
loading... -
-
CDK2-IN-56
0 ImagesCat. No.: HY-10793CAS No.: 802536-13-6 -
loading...Please select quantityObtenir un devis
August 31
-
Please select quantity
August 31
Obtenir un devis
loading... -
-
CDK2-IN-14-d3
0 ImagesCat. No.: HY-151580SCAS No.: 2498658-25-4CDK2-IN-14-d3 is a potent and selective CDK2 inhibitor. CDK2-IN-14-d3 can be used in research of cancer. -
loading...Please select quantityObtenir un devis
August 31
-
Please select quantity
August 31
Obtenir un devis
loading... -
-
CDK7-IN-27
0 ImagesCat. No.: HY-162416CAS No.: 3025006-89-4CDK7-IN-27 (Compound 37) is a selective inhibitor for cyclin-dependent kinase 7 (CDK7), with Ki of 3 nM. CDK7-IN-27 arrests the cell cycle at G0/G1 phase. -
loading...Please select quantityObtenir un devis
August 31
-
Please select quantity
August 31
Obtenir un devis
loading... -
-
UNC10112785
0 ImagesCat. No.: HY-128491CAS No.: 748142-06-5UNC10112785 is a serine/threonine kinase inhibitor with a human GSK-3β IC50 of 0.031 μM, human CDK-2 IC50 of 0.016 μM, and human CDK-4 IC50 of 1.99 μM. UNC10112785 can be used for the research of type 2 diabetes. -
loading...Please select quantityObtenir un devis
August 31
-
Please select quantity
August 31
Obtenir un devis
loading... -
-
Avotaciclib sulfate
0 ImagesCat. No.: HY-137432DCAS No.: 1983984-04-8Synonyms: BEY1107 sulfateAvotaciclib (BEY1107) sulfate is an orally active cyclin-dependent kinase 1 (CDK1) inhibitor. Avotaciclib sulfate can inhibit the proliferation and induce apoptosis of tumor cells. Avotaciclib sulfate can be used in the research of cancer such as pancreatic cancer and lung cancer. -
loading...Please select quantityObtenir un devis
August 31
-
Please select quantity
August 31
Obtenir un devis
loading... -
-
MPT0L145
0 ImagesCat. No.: HY-122888CAS No.: 2070837-24-8MPT0L145 is a PIK3C3/FGFR inhibitor, with a Kd value of 0.53 nM for PIK3C3. MPT0L145 decreases the phosphorylation of FGFR1, FGFR3 and their downstream proteins (FRS2, ERK and Akt). MPT0L145 induces G0/G1 cell cycle arrest and decreased protein levels of cyclin E. MPT0L145 promotes mitochondrial dysfunction, ROS production, and DNA damage. MPT0L145 is an autophagy inhibitor. MPT0L145 significantly sensitizes cancer cells to targeted or chemotherapeutic agents. MPT0L145 can be used for cancer research, such as bladder cancer and NSCLC. -
loading...Please select quantityObtenir un devis
August 31
-
Please select quantity
August 31
Obtenir un devis
loading... -
-
Cdk12 Mouse Pre-designed siRNA Set A
0 ImagesCat. No.: HY-RS02357 -
loading...Please select quantityObtenir un devis
August 31
-
Please select quantity
August 31
Obtenir un devis
loading... -
-
Hsp90-IN-42
0 ImagesCat. No.: HY-176279Hsp90-IN-42 is a heat shock protein 90 (Hsp90) inhibitor with an IC50 of 15.65 nM against human targets. Hsp90-IN-42 destabilizes EGFR and inhibits the activation of the EGFR-Akt signaling pathway. Hsp90-IN-42 suppresses the proliferation and migration of cancer cells, induces cell cycle arrest by downregulating CDK12 and CDK13, and triggers mild apoptosis via downregulating Bcl-2 and upregulating Bax. Hsp90-IN-42 inhibits tumor growth in xenograft mouse models. Hsp90-IN-42 can be used in research related to colorectal cancer. -
loading...Please select quantityObtenir un devis
August 31
-
Please select quantity
August 31
Obtenir un devis
loading... -
- Cdc7-IN-20
-
loading...Please select quantityObtenir un devis
August 31
-
Please select quantity
August 31
Obtenir un devis
loading... -
-
5-HT6 inverse agonist 1
0 ImagesCat. No.: HY-168333CAS No.: 2727088-38-05-HT6 inverse agonist 1 (Compound 33) is an antagonist for 5-HT6 receptor with a Ki of 23 nM and a Kb of 6.62 nM. 5-HT6 inverse agonist 1 inhibits the 5-HT6R mediated Cdk5 and mTOR signaling pathway. 5-HT6 inverse agonist 1 reduces tactile hypersensitivity in spinal nerve ligation (SNL)-induced rat model. -
loading...Please select quantityObtenir un devis
August 31
-
Please select quantity
August 31
Obtenir un devis
loading... -
-
VMY-1-101
0 ImagesCat. No.: HY-182383CAS No.: 1209002-42-5VMY-1-101 is a fluorescent cyclin-dependent kinase (CDK) inhibitor, with an excitation of 410 nm and emission of 512 nm. VMY-1-101 competitively inhibits ATP binding to CDKs. VMY-1-101 induces G2/M cell cycle arrest in human breast cancer cells. VMY-1-101 induces modest apoptosis in human breast cancer cells. VMY-1-101 blocks proliferation of human breast cancer cells, including multidrug resistance-positive cells, and is not a substrate for p-glycoprotein. VMY-1-101 localizes to the cytoplasm of human breast cancer cells. VMY-1-101 shows increased binding to human breast cancer tissue compared to fluorophore alone. VMY-1-101 can be used for the research of breast cancer. -
loading...Please select quantityObtenir un devis
August 31
-
Please select quantity
August 31
Obtenir un devis
loading... -
-
FLT3/CDK4-IN-1
0 ImagesCat. No.: HY-115904CAS No.: 2762296-44-4 -
loading...Please select quantityObtenir un devis
August 31
-
Please select quantity
August 31
Obtenir un devis
loading... -
-
VEGFR2-IN-86
0 ImagesCat. No.: HY-182789VEGFR2-IN-86 is a dual VEGFR2/CDK2 inhibitor, with an IC50 of 0.06 μM against VEGFR2 and an IC50 of 0.78 μM against CDK2. VEGFR2-IN-86 induces G-phase cell cycle arrest, reduces colony-forming ability and tumor cell migration capacity, and exerts antiproliferative activity in cancer cells. VEGFR2-IN-86 can be used for the research of breast cancer and prostate cancer. -
loading...Please select quantityObtenir un devis
August 31
-
Please select quantity
August 31
Obtenir un devis
loading... -
- CDK2-IN-59
-
loading...Please select quantityObtenir un devis
August 31
-
Please select quantity
August 31
Obtenir un devis
loading... -
-
Isosilybin B (Standard)
0 ImagesCat. No.: HY-N7045RCAS No.: 142796-22-3Isosilybin B (Standard) is the analytical standard of Isosilybin B (HY-N7045). This product is intended for research and analytical applications. Isosilybin B is a flavonolignan. Isosilybin B can be isolated from Silybum marianum. Isosilybin B can regulate cell cycle-related proteins (e.g., reduce cyclins (D3, D1, A, E), Cdk4, Cdk2, Cdc25A), and activate Caspases (Caspase-9 and Caspase-3). Isosilybin B can promote Apoptosis, reduce androgen receptor (AR) and PSA. Isosilybin B has anticancer activity against prostate cancer. -
loading...Please select quantityObtenir un devis
August 31
-
Please select quantity
August 31
Obtenir un devis
loading... -
No matching results
No matching results
No matching results
No matching results
-
loading...Please select quantityObtenir un devis
August 31
-
Please select quantity
August 31
Obtenir un devis
loading... -
No matching results
No matching results
No matching results
No matching results
No matching results
No matching results
No matching results
No matching results
No matching results
No matching results
Your Search Returned No Results.
Sorry. There is currently no product that acts on isoform Bcl-2, Bcl-W and Bim together.Please
try each isoform separately.